Welcome to our dedicated page for HANOVER INSURANCE GROUP SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HANOVER INSURANCE GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HANOVER INSURANCE GROUP's regulatory disclosures and financial reporting.
T. Rowe Price Associates, Inc., a Maryland-based investment manager, reports beneficial ownership in Hanover Insurance Group Inc. common stock. The firm reports holding 1,831,584 shares, representing 5.2% of the outstanding common stock, identified by CUSIP 410867105.
The firm reports sole voting power1,819,788 shares and sole dispositive power1,831,584 shares, with no shared voting or dispositive power. T. Rowe Price Associates states that this report should not be construed as an admission that it is the beneficial owner of these securities, and such beneficial ownership is expressly denied.
A holder of THG common stock has indicated an intention to sell up to 1,200 shares of common stock through Stifel Nicolaus & Company Inc., with an aggregate market value of $274,896.00, on or after 08/04/2026 on the NYSE.
The shares to be sold are associated with restricted stock granted as equity compensation on 05/10/2022 (946 shares) and 05/14/2025 (977 shares).
Hanover Insurance Group director Theodore H. Bunting Jr. reported selling a total of 1,200 shares of common stock in two open-market or private transactions, 600 shares at $228.03 on August 5, 2026 and 600 at $230.20 on August 6, 2026. The trades were not reported under a Rule 10b5-1 trading plan.
Hanover Insurance Group, Inc. director Jane D. Carlin reported a sale of 1,000 shares of Common Stock on August 3, 2026 at $231.50 per share. After this open-market sale, she directly holds 2,269.767 shares, excluding 2,306 shares held indirectly in a Rabbi Trust under deferral agreements.
A shareholder of the company with symbol THG has filed to sell 1,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 08/03/2026 on the NYSE. The planned sale is based on a reference aggregate value of $231,499.40.
The 1,000 shares to be sold were acquired as restricted stock that vested on 01/02/2026 under a registered compensation plan, with the issuer listed as the source of those shares.
Hanover Insurance Group Executive Vice President Jeffrey M. Farber exercised stock options for 66,295 shares of common stock on July 29, 2026, at exercise prices between $115.3500 and $118.5400 per share. As part of a net exercise, the company withheld 49,330 shares to cover the exercise price and taxes, resulting in a net issuance of 16,965 shares of Hanover common stock to Farber.
The Hanover Insurance Group, Inc. reported strong profitability for the quarter and six months ended June 30, 2026. Second‑quarter total revenues were $1,726.2 million, up from $1,654.4 million a year earlier, driven primarily by higher premiums of $1,597.6 million and net investment income of $119.6 million.
Quarterly net income rose to $191.6 million, compared with $157.1 million, with diluted earnings per share of $5.38 versus $4.30. For the first half of 2026, net income was $378.4 million and diluted EPS $10.58, up from $285.3 million and $7.80. Operating cash flow for the half-year was $331.1 million. The investment portfolio totaled $10,902.0 million, including fixed maturities at fair value of $10,061.1 million; management characterizes gross unrealized losses on these securities as non‑credit related. As of June 30, 2026, total assets were $16,863.9 million, shareholders’ equity $3,672.5 million, and debt $844.0 million, while cash and cash equivalents declined to $266.1 million after sizable investing activity, debt repayment, and share repurchases.
The Hanover Insurance Group reported record second-quarter 2026 net income of $191.6 million, or $5.38 per diluted share, up from $157.1 million, or $4.30, a year earlier. Operating income was $189.2 million, or $5.31 per diluted share. The consolidated combined ratio was 91.2%, and 85.5% excluding catastrophes, with catastrophe losses of $91.8 million, or 5.7 points of the combined ratio. Net premiums written grew 4.6% to $1,656.8 million, and net investment income increased 13.4% to $119.6 million. Net and operating return on equity were 21.2% and 19.8%, respectively.
By segment, Core Commercial net premiums written rose 7.2% and Specialty 4.4%, while Personal Lines grew 2.6%. Core Commercial and Specialty generated operating income before taxes of $77.5 million and $68.4 million, respectively, while Personal Lines operating income before taxes increased to $104.9 million, with a combined ratio of 88.9% versus 95.5% in the prior-year quarter. Book value per share was $105.40 at June 30, 2026, compared to $89.62 a year earlier; excluding net unrealized depreciation on fixed maturity investments, net of tax, book value per share was $111.26. The company repurchased approximately 291,000 shares for about $55 million in the quarter and 827,000 shares for about $149 million year-to-date through July 24, 2026, and had approximately $660 million of remaining capacity under its $700 million share repurchase authorization.
The Hanover Insurance Group, Inc. announced a planned CEO succession. President and CEO John C. Roche will retire as CEO and board member effective December 31, 2026, following a 40-year career in the insurance industry, and will remain in an advisory role through January 8, 2027.
The board has appointed Richard W. Lavey, currently executive vice president and chief operating officer, as CEO-Elect, with the intent to make him CEO upon Roche’s retirement and to elect him to the board effective January 1, 2027. The company states that Roche’s retirement is not related to any disagreement over its operations, policies, or practices, and plans to address the transition on a July 29, 2026 earnings call and at an investor day on September 17, 2026.
LANE KATHY S reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director Kathy S. Lane reported a small equity award. She received 3.767 shares of common stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan, tied to dividend equivalent rights on previously granted RSUs.
After this grant, Lane holds 2,772.767 shares of common stock directly. Footnotes state the award will vest on the earlier of one year from the original RSU grant date or the next annual meeting, and that she has elected to defer the grant upon vesting under a deferral agreement. The disclosure also notes an additional 4,829 shares held indirectly in a Rabbi Trust pursuant to deferral agreements.